• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体脂肪组织的鸟枪法蛋白质谱及其与全身性淀粉样变性的关系变化。

Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses.

机构信息

Institute for Biomedical Technologies (ITB-CNR) , Segrate, Italy.

出版信息

J Proteome Res. 2013 Dec 6;12(12):5642-55. doi: 10.1021/pr400583h. Epub 2013 Oct 21.

DOI:10.1021/pr400583h
PMID:24083510
Abstract

In systemic amyloidosis, accumulation of misfolded proteins as extracellular amyloid fibrils in tissues causes severe organ dysfunction, but the molecular events of tissue damage related to amyloid deposition are still largely unknown. Through the use of the MudPIT proteomic approach, comprehensive protein profiles of human amyloid-affected adipose tissue from patients and its control (non-amyloid-affected) counterpart were acquired. Label-free comparison between patients and controls made it possible to highlight differences related to the presence of amyloid, by describing up- and down-represented proteins, connected into interacting networks. In particular, extracellular matrix (ECM), protein folding, lipid metabolism, and mitochondrial functions were among the most affected structural/functional pathways. The reported results, obtained with no a priori hypotheses, represent a significant step forward in the clarification of the molecular mechanisms involved in amyloidoses at tissue level and are the premise for understanding protein misfolding diseases.

摘要

在系统性淀粉样变性中,错误折叠的蛋白质在组织中积累为细胞外的淀粉样纤维,导致严重的器官功能障碍,但与淀粉样沉积相关的组织损伤的分子事件在很大程度上仍不清楚。通过使用 MudPIT 蛋白质组学方法,获得了来自患者的受淀粉样蛋白影响的脂肪组织及其对照(不受淀粉样蛋白影响)的综合蛋白质图谱。患者与对照组之间的无标记比较使我们能够通过描述上调和下调的蛋白质并将其连接成相互作用的网络,突出与淀粉样蛋白存在相关的差异。特别是细胞外基质 (ECM)、蛋白质折叠、脂质代谢和线粒体功能是受影响最严重的结构/功能途径之一。这些没有先验假设的报告结果代表了在组织水平阐明淀粉样变性相关分子机制的重要一步,也是理解蛋白质错误折叠疾病的前提。

相似文献

1
Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses.人体脂肪组织的鸟枪法蛋白质谱及其与全身性淀粉样变性的关系变化。
J Proteome Res. 2013 Dec 6;12(12):5642-55. doi: 10.1021/pr400583h. Epub 2013 Oct 21.
2
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.蛋白质错误折叠、淀粉样纤维形成与人类疾病:过去十年研究进展综述。
Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.
3
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.脂肪组织系统性淀粉样变性蛋白质组中的淀粉样蛋白生成及相关蛋白
Mol Cell Proteomics. 2008 Aug;7(8):1570-83. doi: 10.1074/mcp.M700545-MCP200. Epub 2008 May 12.
4
Proteomics in protein misfolding diseases.蛋白质错误折叠疾病中的蛋白质组学
Clin Chem Lab Med. 2009;47(6):627-35. doi: 10.1515/CCLM.2009.164.
5
Proteomic typing of amyloid deposits in systemic amyloidoses.系统性淀粉样变性中淀粉样沉积物的蛋白质组学分型。
Amyloid. 2011 Dec;18(4):177-82. doi: 10.3109/13506129.2011.630762.
6
Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.解析系统性轻链(AL)淀粉样变性的分子特征:蛋白质组学的贡献。
Medicina (Kaunas). 2021 Aug 31;57(9):916. doi: 10.3390/medicina57090916.
7
Systemic amyloidoses.系统性淀粉样变性。
Annu Rev Biochem. 2013;82:745-74. doi: 10.1146/annurev-biochem-072611-130030. Epub 2013 Feb 28.
8
Diagnosing amyloidosis.诊断淀粉样变性病。
Scand J Rheumatol. 1995;24(6):327-9. doi: 10.3109/03009749509095175.
9
[Amyloidosis: a model of misfolded protein disorder].[淀粉样变性:一种错误折叠蛋白疾病的模型]
Med Sci (Paris). 2005 Jun-Jul;21(6-7):627-33. doi: 10.1051/medsci/2005216-7627.
10
Protein misfolding, functional amyloid, and human disease.蛋白质错误折叠、功能性淀粉样蛋白与人类疾病
Annu Rev Biochem. 2006;75:333-66. doi: 10.1146/annurev.biochem.75.101304.123901.

引用本文的文献

1
Histological and proteomic characterization of musculoskeletal amyloidomas.肌肉骨骼淀粉样瘤的组织学和蛋白质组学特征
Pathologica. 2025 Jun;117(3):278-287. doi: 10.32074/1591-951X-939.
2
Computational Tools and Methods for the Study of Systemic Amyloidosis at the Clinical and Molecular Level.临床和分子水平系统性淀粉样变性研究的计算工具与方法
Methods Mol Biol. 2025;2884:369-387. doi: 10.1007/978-1-0716-4298-6_22.
3
Myocardial inflammatory cells in cardiac amyloidosis.心脏淀粉样变性中的心肌炎性细胞。
Sci Rep. 2024 Oct 7;14(1):23313. doi: 10.1038/s41598-024-74289-5.
4
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?AL 淀粉样变性患者皮下脂肪活检中的蛋白质网络:不仅仅是诊断?
Cells. 2023 Feb 22;12(5):699. doi: 10.3390/cells12050699.
5
Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.解析系统性轻链(AL)淀粉样变性的分子特征:蛋白质组学的贡献。
Medicina (Kaunas). 2021 Aug 31;57(9):916. doi: 10.3390/medicina57090916.
6
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two Centres.基于蛋白质组学的临床淀粉样变分型:两个中心的性能评估和数据共享。
Molecules. 2021 Mar 29;26(7):1913. doi: 10.3390/molecules26071913.
7
Disrupting the DREAM transcriptional repressor complex induces apolipoprotein overexpression and systemic amyloidosis in mice.破坏 DREAM 转录抑制复合物可诱导小鼠载脂蛋白过度表达和全身淀粉样变性。
J Clin Invest. 2021 Feb 15;131(4). doi: 10.1172/JCI140903.
8
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.心脏轻链淀粉样变中轻链片段化位点的质谱分析:对蛋白水解时间的深入了解。
J Biol Chem. 2020 Dec 4;295(49):16572-16584. doi: 10.1074/jbc.RA120.013461. Epub 2020 Sep 20.
9
Identification of Maltase Glucoamylase as a Biomarker of Acute Kidney Injury in Patients with Cirrhosis.鉴定麦芽糖酶-葡糖淀粉酶作为肝硬化患者急性肾损伤的生物标志物
Crit Care Res Pract. 2019 Apr 16;2019:5912804. doi: 10.1155/2019/5912804. eCollection 2019.
10
Time for new imaging and therapeutic approaches in cardiac amyloidosis.心脏淀粉样变性需要新的成像和治疗方法的时候了。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1402-1406. doi: 10.1007/s00259-019-04325-4. Epub 2019 Apr 23.